BMI Capital’s Celgene Corp CELG Stock Holding History

BMI Capital’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-40,540	Closed	-$3.12M	–	82
2013 Q3	$3.12M	Buy	40,540 +600	+2%	+$42K	1.95%	8
2013 Q2	$2.34M	Buy	+39,940	New	+$2.4M	1.5%	16

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BMI Capital's CELG Position: Q4 2013 in Review

BMI Capital sold out of Celgene Corp (CELG) in Q4 2013, closing a stake of 40,540 shares — an estimated $3.12M sold.

BMI Capital first reported a position in CELG in Q2 2013 and held it in 2 quarters. The position peaked at $3.12M in Q3 2013. 983 funds tracked by Wall St. Rank hold CELG as of Q4 2013.

BMI Capital reported no remaining Celgene Corp position as of Q4 2013 after selling out during the quarter.
BMI Capital sold 40,540 Celgene Corp shares in Q4 2013, an estimated $3.12M.
BMI Capital first reported a position in Celgene Corp in Q2 2013 and held it in 2 quarters.
BMI Capital's Celgene Corp position peaked at $3.12M in Q3 2013.
983 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2013.

Based on BMI Capital's 13F filing for Q4 2013, filed 7 Feb 2014.